Global expression of prophage genes in Escherichia coli O157:H7 strain EDL933 in response to norfloxacin.
We investigated the influence of a low concentration of the gyrase inhibitor norfloxacin on the transcriptome of enterohemorrhagic Escherichia coli O157:H7 strain EDL933. For this purpose, we used a commercial DNA microarray containing oligonucleotides specific for E. coli O157:H7 strains EDL933 and RIMD0509952 and E. coli K-12 strain MG1655. Under the conditions applied, 5,963 spots (94% of all spots) could be analyzed. Among these, 118 spots (P < 0.05) indicated transcriptional upregulation and 122 spots (P < 0.05) indicated transcriptional downregulation of the E. coli genes present on the array. Eighty-five upregulated EDL933 genes were phage borne. Fifty-two of them could be ascribed to the Shiga toxin-encoding phages (Stx phages) BP-933W and CP-933V; the other 33 genes belonged to non-Stx prophage elements in the EDL933 genome. Genes present in the BP-933W prophage genome were induced most strongly up to 158-fold in the case of stxA(2) upon induction with norfloxacin. Twenty-two additional upregulated genes appeared to be E. coli O157:H7 strain RIMD0509952-specific phage elements, and the remaining 11 genes were related mainly to recombination and stress functions. Downregulation was indicated predominantly for genes responsible for bacterial primary metabolism, such as energy production, cell division, and amino acid biosynthesis. Interestingly, some genes present in the locus of enterocyte effacement appeared to be downregulated. The results of the study have shown that a low concentration of norfloxacin has profound effects on the transcriptome of E. coli O157:H7.
Herold
Sylvia
S
Institut für Medizinishe Mikrobioloie und Hygiene, Technische Universität Dresden, Dresden, Germany.
Siebert
Jutta
J
Huber
Andrea
A
Schmidt
Herbert
H
D000890:Anti-Infective Agents / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D019453:Escherichia coli O157 / Q000187:drug effects* / Q000235:genetics* / Q000254:growth & development; D020869:Gene Expression Profiling; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects*; D009643:Norfloxacin / Q000494:pharmacology*; D020411:Oligonucleotide Array Sequence Analysis; D016133:Polymerase Chain Reaction; D039002:Prophages / Q000235:genetics*; D022621:Shiga Toxin / Q000096:biosynthesis
D000890:Anti-Infective Agents; D004791:Enzyme Inhibitors; D022621:Shiga Toxin; D009643:Norfloxacin
Lancet Infect Dis. 2004 Feb;4(2):100-11
14871635
Pathol Biol (Paris). 1987 Dec;35(10 Pt 2):1370-6
3325898
Crit Rev Microbiol. 1982;9(2):101-38
7042209
N Engl J Med. 1983 Mar 24;308(12):681-5
6338386
Lancet. 1983 Sep 3;2(8349):573
6136724
J Infect Dis. 2000 Feb;181(2):664-70
10669353
Microbiology. 2000 May;146 ( Pt 5):1085-90
10832635
Annu Rev Biochem. 2000;69:183-215
10966457
Emerg Infect Dis. 2000 Sep-Oct;6(5):458-65
10998375
Mol Microbiol. 2000 Oct;38(2):368-80
11069662
Nature. 2001 Jan 25;409(6819):529-33
11206551
J Bacteriol. 2001 Mar;183(6):2081-5
11222608
DNA Res. 2001 Feb 28;8(1):11-22
11258796
Mol Microbiol. 1991 Aug;5(8):1817-22
1766367
Infection. 1992 Jan-Feb;20(1):25-9
1563808
J Bacteriol. 1992 Dec;174(23):7495-9
1447124
Mol Microbiol. 1993 Nov;10(3):473-81
7968526
Science. 1997 Sep 5;277(5331):1453-62
9278503
Microbiol Mol Biol Rev. 1997 Sep;61(3):377-92
9293187
Nat Biotechnol. 1997 Dec;15(13):1359-67
9415887
Clin Microbiol Rev. 1998 Jan;11(1):142-201
9457432
Mol Microbiol. 1998 Jun;28(6):1255-67
9680214
Eur J Clin Microbiol Infect Dis. 1998 Nov;17(11):761-6
9923515
Mol Microbiol. 1998 Dec;30(5):905-10
9988468
J Bacteriol. 1999 Mar;181(6):1767-78
10074068
J Bacteriol. 1999 Apr;181(7):2257-60
10094706
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3807-12
10097119
Curr Microbiol. 1999 Aug;39(2):68-72
10398829
Appl Environ Microbiol. 1999 Sep;65(9):3855-61
10473386
Nucleic Acids Res. 1999 Oct 1;27(19):3821-35
10481021
Emerg Infect Dis. 1999 Sep-Oct;5(5):607-25
10511517
Can J Microbiol. 1999 Sep;45(9):732-9
10526400
J Bacteriol. 2001 Sep;183(17):5187-97
11489873
Bioessays. 2001 Aug;23(8):708-15
11494319
Pediatr Nephrol. 2001 Oct;16(10):823-39
11605791
J Bacteriol. 2002 May;184(9):2546-51
11948171
Mol Microbiol. 2002 Apr;44(1):89-105
11967071
Nucleic Acids Res. 2002 May 1;30(9):e36
11972351
Infect Immun. 2002 Aug;70(8):3985-93
12117903
Antimicrob Agents Chemother. 2002 Nov;46(11):3478-83
12384353
Annu Rev Genet. 2002;36:175-203
12429691
J Bacteriol. 2003 Jan;185(1):155-64
12486052
Mol Microbiol. 2003 Feb;47(4):879-89
12581346
J Mol Microbiol Biotechnol. 2003;5(2):105-22
12736533
Mol Microbiol. 2003 Jun;48(6):1633-45
12791144
J Bacteriol. 2003 Oct;185(20):6158-70
14526028
Curr Opin Microbiol. 2003 Oct;6(5):482-9
14572541
Genome Res. 2003 Nov;13(11):2435-43
14597655
Arzneimittelforschung. 1985;35(10):1600-3
2934069
Microbiol Rev. 1987 Jun;51(2):206-20
3299029
Infect Immun. 2004 Sep;72(9):5452-9
15322044